179 POSTER Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma

2008 ◽  
Vol 6 (12) ◽  
pp. 57 ◽  
Author(s):  
J.C. Soria ◽  
R. Plummer ◽  
A. Soto ◽  
C. Massard ◽  
H. Calvert ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Cancer Drug ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Weekly Infusion ◽  
Anti Cancer

Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2506-2506 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Filip Janku ◽  
Anthony W. Tolcher ◽  
Manish R. Patel ◽  
Ryan J. Sullivan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Advanced Solid Tumors ◽  
The Novel

Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e13024-e13024 ◽  
Author(s):  
L. Chen ◽  
H. Shiah ◽  
T. Chao ◽  
R. K. Hsieh ◽  
G. Chen ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Weekly Infusion

Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors

2005 ◽  
Vol 55 (5) ◽  
pp. 497-501 ◽  
Author(s):  
Maria Luisa Veronese ◽  
Keith Flaherty ◽  
Amy Kramer ◽  
Barbara A. Konkle ◽  
Mark Morgan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
The Novel

scholarly journals Erratum to: Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

2013 ◽  
Vol 31 (3) ◽  
pp. 799-799
Author(s):  
Christophe Massard ◽  
Jane Margetts ◽  
Nadia Amellal ◽  
Yvette Drew ◽  
Ratislav Bahleda ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Weekly Infusion

Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

2012 ◽  
Vol 31 (3) ◽  
pp. 623-630 ◽  
Author(s):  
Christophe Massard ◽  
Jane Margetts ◽  
Nadia Amellal ◽  
Yvette Drew ◽  
Ratislav Bahleda ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Weekly Infusion
Sign in / Sign up

Export Citation Format

Share Document